The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Role of the Tumor Microenvironment in Breast Cancer
Abstract
In recent years, it has been shown that breast cancer consists not only of neoplastic cells, but also of significant alterations in the surrounding stroma or tumor microenvironment. These alterations are now recognized as a critical element for breast cancer development and progression, as well as potential therapeutic targets. Various components of the breast cancer microenvironment, such as suppressive immune cells, soluble factors and altered extracellular matrix, act together to impede effective antitumor immunity and promote breast cancer progression and metastasis. Stromal cells in the breast cancer microenvironment are characterized by molecular alterations and aberrant signaling pathways, some of which are prognostic of clinical outcome. Several new therapies targeting stromal components are in development or undergoing clinical trials. We focus herein on the composition of the breast cancer microenvironment and concomitant molecular alterations, the specific interplay between various cell types and cancer cells, and the clinical implications of these findings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Lysyl oxidase is essential for hypoxia-induced metastasis
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006) · Nature · doi:10.1038/nature04695 · Cited by 1,309
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Safety, activity, and immune correlates of anti–PD-1 antibody in cancer
Topalian, S. L., Hodi, F. S., Brahmer, J. R., Gettinger, S. N., Smith, D. C., McDermott, D. F., Powderly, J. D., Carvajal, R. D., Sosman, J. A., Atkins, M. B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200690 · Cited by 12,628
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer
Brahmer, J. R., Tykodi, S. S., Chow, L. Q. M., Hwu, W.-J., Topalian, S. L., Hwu, P., Drake, C. G., Camacho, L. H., Kauh, J., Odunsi, K., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200694 · Cited by 7,945
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
Schreiber, R. D., Old, L. J., & Smyth, M. J. (2011) · Science · doi:10.1126/science.1203486 · Cited by 6,474
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
Dong, H., Strome, S. E., Salomao, D. R., Tamura, H., Hirano, F., Flies, D. B., Roche, P. C., Lu, J., Zhu, G., Tamada, K., et al. (2002) · Nature Medicine · doi:10.1038/nm730 · Cited by 5,025
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F. T., Csiszar, K., Giaccia, A., Weninger, W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.10.027 · Cited by 4,101
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Microenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684
Steinman, R. M., Hawiger, D., & Nussenzweig, M. C. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141040 · Cited by 3,122
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
Miller, K., Wang, M., Gralow, J., Dickler, M., Cobleigh, M., Perez, E. A., Shenkier, T., Cella, D., & Davidson, N. E. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072113 · Cited by 3,081
The extracellular matrix: A dynamic niche in cancer progression
Lu, P., Weaver, V. M., & Werb, Z. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201102147 · Cited by 3,024
Brahmer, J. R., Drake, C. G., Wollner, I., Powderly, J. D., Picus, J., Sharfman, W. H., Stankevich, E., Pons, A., Salay, T. M., McMiller, T. L., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.7609 · Cited by 2,961
DeNardo, D. G., Brennan, D. J., Rexhepaj, E., Ruffell, B., Shiao, S. L., Madden, S. F., Gallagher, W. M., Wadhwani, N., Keil, S. D., Junaid, S. A., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8274.cd-10-0028 · Cited by 1,715
Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
Ebos, J. M. L., Lee, C. R., Cruz-Munoz, W., Bjarnason, G. A., Christensen, J. G., & Kerbel, R. S. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.021 · Cited by 1,709
Stromal gene expression predicts clinical outcome in breast cancer
Finak, G., Bertos, N., Pepin, F., Sadekova, S., Souleimanova, M., Zhao, H., Chen, H., Omeroglu, G., Meterissian, S., Omeroglu, A., et al. (2008) · Nature Medicine · doi:10.1038/nm1764 · Cited by 1,687
Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation
Solinas, G., Germano, G., Mantovani, A., & Allavena, P. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0609385 · Cited by 1,425
Tumor-Infiltrating CD8+Lymphocytes Predict Clinical Outcome in Breast Cancer
Mahmoud, S. M. A., Paish, E. C., Powe, D. G., Macmillan, R. D., Grainge, M. J., Lee, A. H. S., Ellis, I. O., & Green, A. R. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.5037 · Cited by 1,367
Tumor Self-Seeding by Circulating Cancer Cells
Kim, M.-Y., Oskarsson, T., Acharyya, S., Nguyen, D. X., Zhang, X. H.-F., Norton, L., & Massagué, J. (2009) · Cell · doi:10.1016/j.cell.2009.11.025 · Cited by 1,335
Molecular characterization of the tumor microenvironment in breast cancer
Allinen, M., Beroukhim, R., Cai, L., Brennan, C., Lahti-Domenici, J., Huang, H., Porter, D., Hu, M., Chin, L., Richardson, A., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.010 · Cited by 1,299
“Re-educating” tumor-associated macrophages by targeting NF-κB
Hagemann, T., Lawrence, T., McNeish, I., Charles, K. A., Kulbe, H., Thompson, R. G., Robinson, S. C., & Balkwill, F. R. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080108 · Cited by 792
The significance of cancer cell expression of the chemokine receptor CXCR4
Balkwill, F. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2003.10.003 · Cited by 758
CXCR4 Regulates Growth of Both Primary and Metastatic Breast Cancer
Smith, M. C. P., Luker, K. E., Garbow, J. R., Prior, J. L., Jackson, E., Piwnica-Worms, D., & Luker, G. D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1844 · Cited by 715
Rolny, C., Mazzone, M., Tugues, S., Laoui, D., Johansson, I., Coulon, C., Squadrito, M. L., Segura, I., Li, X., Knevels, E., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.11.009 · Cited by 695
Tan, W., Zhang, W., Strasner, A., Grivennikov, S., Cheng, J. Q., Hoffman, R. M., & Karin, M. (2011) · Nature · doi:10.1038/nature09707 · Cited by 647
Matrix metalloproteinases in cancer: Prognostic markers and therapeutic targets
Vihinen, P., & Kähäri, V. (2002) · International Journal of Cancer · doi:10.1002/ijc.10329 · Cited by 637
Blank, C., Gajewski, T. F., & Mackensen, A. (2005) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-004-0593-x · Cited by 637
Gene expression profiling of the tumor microenvironment during breast cancer progression
Ma, X.-J., Dahiya, S., Richardson, E., Erlander, M., & Sgroi, D. C. (2009) · Breast Cancer Research · doi:10.1186/bcr2222 · Cited by 629
A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer
Farmer, P., Bonnefoi, H., Anderle, P., Cameron, D., Wirapati, P., Becette, V., André, S., Piccart, M., Campone, M., Brain, E., et al. (2009) · Nature Medicine · doi:10.1038/nm.1908 · Cited by 623
Breast cancer stem cells, cytokine networks, and the tumor microenvironment
Korkaya, H., Liu, S., & Wicha, M. S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57099 · Cited by 616
Malignant cells facilitate lung metastasis by bringing their own soil
Duda, D. G., Duyverman, A. M. M. J., Kohno, M., Snuderl, M., Steller, E. J. A., Fukumura, D., & Jain, R. K. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016234107 · Cited by 594
Muenst, S., Schaerli, A. R., Gao, F., Däster, S., Trella, E., Droeser, R. A., Muraro, M. G., Zajac, P., Zanetti, R., Gillanders, W. E., et al. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-2988-5 · Cited by 558
Self-citationBone marrow contribution to tumor-associated myofibroblasts and fibroblasts
Direkze, N. C., Hodivala-Dilke, K., Jeffery, R., Hunt, T., Poulsom, R., Oukrif, D., Alison, M. R., & Wright, N. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1708 · Cited by 530
Distinct epigenetic changes in the stromal cells of breast cancers
Hu, M., Yao, J., Cai, L., Bachman, K. E., van den Brûle, F., Velculescu, V., & Polyak, K. (2005) · Nature Genetics · doi:10.1038/ng1596 · Cited by 520
Cancer Immunotherapy by Dendritic Cells
Melief, C. J. M. (2008) · Immunity · doi:10.1016/j.immuni.2008.08.004 · Cited by 508
Regulation of In Situ to Invasive Breast Carcinoma Transition
Hu, M., Yao, J., Carroll, D. K., Weremowicz, S., Chen, H., Carrasco, D., Richardson, A., Violette, S., Nikolskaya, T., Nikolsky, Y., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.03.007 · Cited by 502
Treatment-Related Mortality With Bevacizumab in Cancer Patients: A Meta-analysis
Ranpura, V., Hapani, S., & Wu, S. (2011) · JAMA · doi:10.1001/jama.2011.51 · Cited by 428
Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis
Jung, Y., Kim, J. K., Shiozawa, Y., Wang, J., Mishra, A., Joseph, J., Berry, J. E., McGee, S., Lee, E., Sun, H., et al. (2013) · Nature Communications · doi:10.1038/ncomms2766 · Cited by 423
Martinez-Outschoorn, U. E., Lisanti, M. P., & Sotgia, F. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.01.005 · Cited by 423
The microenvironment in breast cancer progression: biology and implications for treatment
Place, A. E., Jin Huh, S., & Polyak, K. (2011) · Breast Cancer Research · doi:10.1186/bcr2912 · Cited by 413
Jekyll and Hyde: the role of the microenvironment on the progression of cancer
Allen, M., & Louise Jones, J. (2011) · The Journal of Pathology · doi:10.1002/path.2803 · Cited by 375
Tsutsui, S., Yasuda, K., Suzuki, K., Tahara, K., Higashi, H., & Era, S. (2005) · Oncology Reports · doi:10.3892/or.14.2.425 · Cited by 366
Rech, A. J., Mick, R., Martin, S., Recio, A., Aqui, N. A., Powell, D. J., Colligon, T. A., Trosko, J. A., Leinbach, L. I., Pletcher, C. H., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003330 · Cited by 337
Muenst, S., Soysal, S. D., Gao, F., Obermann, E. C., Oertli, D., & Gillanders, W. E. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2581-3 · Cited by 334
Self-citationMicroenvironmental regulation of cancer development
Hu, M., & Polyak, K. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2007.12.006 · Cited by 330
Mantovani, A., & Locati, M. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.113.300168 · Cited by 290
Qiu, W., Hu, M., Sridhar, A., Opeskin, K., Fox, S., Shipitsin, M., Trivett, M., Thompson, E. R., Ramakrishna, M., Gorringe, K. L., et al. (2008) · Nature Genetics · doi:10.1038/ng.117 · Cited by 282
Mechanisms of osteolytic bone metastases in breast carcinoma
K�k�nen, S.-M., & Mundy, G. R. (2003) · Cancer · doi:10.1002/cncr.11132 · Cited by 269
Programmed death-1 pathway in cancer and autoimmunity
Pedoeem, A., Azoulay-Alfaguter, I., Strazza, M., Silverman, G. J., & Mor, A. (2014) · Clinical Immunology · doi:10.1016/j.clim.2014.04.010 · Cited by 268
Regulatory T cells and treatment of cancer
Curiel, T. J. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.04.008 · Cited by 262
Emerging targets in cancer management: role of the CXCL12/CXCR4 axis
Dubrovska, A., Cojoc, M., Peitzsch, Trautmann, F., Polishchuk, & Telegeev (2013) · OncoTargets and Therapy · doi:10.2147/ott.s36109 · Cited by 254
The immune system and inflammation in breast cancer
Jiang, X., & Shapiro, D. J. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.06.003 · Cited by 240
Madhusudan, S., Foster, M., Muthuramalingam, S. R., Braybrooke, J. P., Wilner, S., Kaur, K., Han, C., Hoare, S., Balkwill, F., Talbot, D. C., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0730 · Cited by 205
Stromal Cell Expression of Caveolin-1 Predicts Outcome in Breast Cancer
Sloan, E. K., Ciocca, D. R., Pouliot, N., Natoli, A., Restall, C., Henderson, M. A., Fanelli, M. A., Cuello-Carrión, F. D., Gago, F. E., & Anderson, R. L. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080924 · Cited by 191
Tumor-Educated CD11bhighIalow Regulatory Dendritic Cells Suppress T Cell Response through Arginase I
Liu, Q., Zhang, C., Sun, A., Zheng, Y., Wang, L., & Cao, X. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803926 · Cited by 186
Fiegl, H., Millinger, S., Goebel, G., Müller-Holzner, E., Marth, C., Laird, P. W., & Widschwendter, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2508 · Cited by 172
Bondareva, A., Downey, C. M., Ayres, F., Liu, W., Boyd, S. K., Hallgrimsson, B., & Jirik, F. R. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005620 · Cited by 159
Zhang, Y., Cheng, S., Zhang, M., Zhen, L., Pang, D., Zhang, Q., & Li, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076147 · Cited by 146
The Role of Type IV Collagen and Basement Membranes in Cancer Progression and Metastasis
Tanjore, H., & Kalluri, R. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.051321 · Cited by 140
Bohling, S. D., & Allison, K. H. (2008) · Modern Pathology · doi:10.1038/modpathol.2008.160 · Cited by 139
Bollyky, P. L., Wu, R. P., Falk, B. A., Lord, J. D., Long, S. A., Preisinger, A., Teng, B. J., Holt, G. E., Standifer, N. E., Braun, K. R., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017360108 · Cited by 137
Tumor growth and angiogenesis are dependent on the presence of immature dendritic cells
Fainaru, O., Almog, N., Yung, C. W., Nakai, K., Montoya‐Zavala, M., Abdollahi, A., D’Amato, R. J., & Ingber, D. E. (2009) · The FASEB Journal · doi:10.1096/fj.09-147025 · Cited by 133
Myoepithelial Cells: Autocrine and Paracrine Suppressors of Breast Cancer Progression
Barsky, S. H., & Karlin, N. J. (2005) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-005-9585-5 · Cited by 132
Hinoda, Y., Okayama, N., Takano, N., et al. (2002) · International Journal of Cancer · doi:10.1002/ijc.10750 · Cited by 131
Expression of CXCR4 and breast cancer prognosis: a systematic review and meta-analysis
Zhang, Z., Ni, C., Chen, W., Wu, P., Wang, Z., Yin, J., Huang, J., & Qiu, F. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-49 · Cited by 129
Stromal caveolin-1 levels predict early DCIS progression to invasive breast cancer
Witkiewicz, A. K., Dasgupta, A., Nguyen, K., Liu, C., Kovatich, A. J., Schwartz, G. F., Pestell, R. G., Sotgia, F., Rui, H., & Lisanti, M. P. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.11.8874 · Cited by 128
Stromal induction of breast cancer: Inflammation and invasion
Radisky, E. S., & Radisky, D. C. (2007) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-007-9037-1 · Cited by 126
CD25+CD4+ Regulatory T-Cells in Cancer
Linehan, D. C., & Goedegebuure, P. S. (2005) · Immunologic Research · doi:10.1385/ir:32:1-3:155 · Cited by 116
Lapatinib and doxorubicin enhance the S tat1‐dependent antitumor immune response
Hannesdóttir, L., Tymoszuk, P., Parajuli, N., Wasmer, M.-H., Philipp, S., Daschil, N., Datta, S., Koller, J., Tripp, C. H., Stoitzner, P., et al. (2013) · European Journal of Immunology · doi:10.1002/eji.201242505 · Cited by 115
Muenst, S. E., Soysal, S. D., Tzankov, A., & Hoeller, S. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.980235 · Cited by 99
Self-citationSignaling pathways in breast cancer: Therapeutic targeting of the microenvironment
Kamdje, A. H. N., Etet, P. F. S., Vecchio, L., Jm, M., Krampera, M., & Lukong, K. E. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.07.034 · Cited by 98
Possible involvement of regulatory T cells in tumor onset and progression in primary breast cancer
Ohara, M., Yamaguchi, Y., Matsuura, K., Murakami, S., Arihiro, K., & Okada, M. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0570-x · Cited by 96
Lotze, M. T. (1997) · Annals of Surgery · doi:10.1097/00000658-199707000-00001 · Cited by 93
Chapon, M., Randriamampita, C., Maubec, E., Badoual, C., Fouquet, S., Wang, S.-F., Marinho, E., Farhi, D., Garcette, M., Jacobelli, S., et al. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.30 · Cited by 86
Baek, S., Kim, C., Kim, S., Kim, Y., Kwon, S. W., Kim, Y., Kim, H., & Lee, H. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-178 · Cited by 83
The metastatic microenvironment of breast cancer: Clinical implications
Coleman, R. E., Gregory, W. M., Marshall, H. C., Wilson, C., & Holen, I. (2013) · The Breast · doi:10.1016/j.breast.2013.07.010 · Cited by 76
Folgueira, M. A. A. K., Maistro, S., Katayama, M. L. H., Roela, R. A., Mundim, F. G. L., Nanogaki, S., de Bock, G. H., & Brentani, M. M. (2013) · Bioscience Reports · doi:10.1042/bsr20130060 · Cited by 74
Anti-tumour activity of bisphosphonates in preclinical models of breast cancer
Holen, I., & Coleman, R. E. (2010) · Breast Cancer Research · doi:10.1186/bcr2769 · Cited by 73
Halting metastasis through CXCR4 inhibition
Ramsey, D. M., & McAlpine, S. R. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.10.138 · Cited by 69
Berkenblit, A., Matulonis, U. A., Kroener, J. F., Dezube, B. J., Lam, G. N., Cuasay, L. C., Brünner, N., Jones, T. R., Silverman, M. H., & Gold, M. A. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2005.05.023 · Cited by 67
Chen, L. C., Tu, S., Huang, C. S., Chen, C. S., Ho, C., Lin, H. W., Lee, C., Chang, H., Chang, C. H., Wu, C.-H., et al. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-1986-8 · Cited by 65
Qi, C., Ning, Y., Han, Y.-S., Min, H.-Y., Ye, H., Zhu, Y.-L., & Qian, K. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1192-2 · Cited by 65
Tumor–stroma crosstalk: targeting stroma in breast cancer
Criscitiello, C., Espósito, A., & Curigliano, G. (2014) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000122 · Cited by 61
Candidate prognostic markers in breast cancer: focus on extracellular proteases and their inhibitors
Walsh, L. A., & Roy, D. (2014) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s46020 · Cited by 60
Park, C., Min, K. N., Son, J., Park, S.-Y., Nam, J., Kim, D., & Sheen, Y. Y. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.05.006 · Cited by 59
Wang, X., Yang, K., Wanyan, P., & Tian, J. H. (2014) · Oncology Letters · doi:10.3892/ol.2014.1982 · Cited by 58
Choi, Y. P., Lee, J. H., Gao, M., Kim, B. G., Kang, S., Kim, S. H., & Cho, N. H. (2014) · International Journal of Cancer · doi:10.1002/ijc.28848 · Cited by 55
Chen, X., Yang, Y.-A., Zhou, Q., Weiss, J. M., Howard, O. Z., McPherson, J. M., Wakefield, L. M., & Oppenheim, J. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085398 · Cited by 55
Bone Marrow–Derived Stromal Cells Express Lineage-Related Messenger RNA Species
Direkze, N. C., Jeffery, R. E., Hodivala‐Dilke, K., Hunt, T., Playford, R. J., Elia, G., Poulsom, R., Wright, N. A., & Alison, M. R. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3202 · Cited by 52
Holliday, D. L., Hughes, S., Shaw, J., Walker, R. A., & Jones, J. L. (2007) · Breast Cancer Research · doi:10.1186/bcr1775 · Cited by 51
Delaloge, S., Wolp-Diniz, R., Byrski, T., Blum, J. L., Gonçalvès, A., Campone, M., Lardelli, P., Kahatt, C. M., Nieto, A., Cullell-Young, M., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu134 · Cited by 48
Pattern response of dendritic cells in the tumor microenvironment and breast cancer
da Cunha, A. (2014) · World Journal of Clinical Oncology · doi:10.5306/wjco.v5.i3.495 · Cited by 46
Harnessing the immune system for the treatment of breast cancer
Jiang, X. (2014) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1300264 · Cited by 36
Valle, P. R. D., Milani, C., Brentani, M. M., Katayama, M. L. H., de Lyra, E. C., Carraro, D. M., Brentani, H., Puga, R., Lima, L. A., Rozenchan, P. B., et al. (2014) · Genetics and Molecular Biology · doi:10.1590/s1415-47572014000400002 · Cited by 35
Brahmer, J. R., Horn, L., Antonia, S. J., Spigel, D. R., Gandhi, L., Sequist, L. V. D., Wigginton, J. M., McDonald, D., Kollia, G. D., Gupta, A. K., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.30.15_suppl.7509 · Cited by 27
He, X., Fang, L., Wang, J., Yi, Y., Zhang, S., & Xie, X. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0294 · Cited by 16
Kontopodis, E., Kentepozidis, N. K., Christophyllakis, C., et al. (2014) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-014-2628-0 · Cited by 10
Cited by
A living biobank of breast cancer organoids captures disease heterogeneity
Sachs, N., de Ligt, J., Kopper, O., Gogola, E., Bounova, G., Weeber, F., Balgobind, A. V., Wind, K., Gracanin, A., Begthel, H., et al. (2018) · Cell · doi:10.1016/j.cell.2017.11.010 · Cited by 1,973
Braman, N., Prasanna, P., Whitney, J., Singh, S., Beig, N., Etesami, M., Bates, D. D. B., Gallagher, K., Bloch, B. N., Vulchi, M., et al. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.2561 · Cited by 327
Peña-Romero, A. C., & Orenes-Piñero, E. (2022) · Cancers · doi:10.3390/cancers14071681 · Cited by 257
The Tumor Microenvironment in Tumorigenesis and Therapy Resistance Revisited
Dzobo, K., Senthebane, D. A., & Dandara, C. (2023) · Cancers · doi:10.3390/cancers15020376 · Cited by 146
Yin, T., Zhao, Z.-B., Guo, J., Wang, T., Yang, J.-B., Wang, C., Long, J., Ma, S., Huang, Q., Zhang, K., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3397 · Cited by 92
Metadata
- Authors
- Soysal, S. D., Tzankov, A., & Muenst, S. E.
- Venue
- Pathobiology
- Publisher
- S. Karger AG
- Published
- 2015
- Volume
- 82
- Issue
- 3-4
- Pages
- 142-152
- ISSN
- 1015-2008 (ISSN-L)
- 1423-0291
- OpenAlex
- W1488814076
- Cited by
- 510
- References
- 100
- FWCI
- 3.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.